Dawn Sanderson Bongiovanni

Dawn Sanderson Bongiovanni serves as the Senior Director of Patient Safety & Pharmacovigilance at HUTCHMED since October 2020. Previously, Bongiovanni held the position of Senior Director of Pharmacovigilance at Braeburn from September 2018 to October 2020, overseeing pharmacovigilance operations such as case processing and aggregate reporting. Prior to that, experience includes roles at sanofi-aventis, where responsibilities comprised the medical and regulatory assessment of serious adverse events and product safety oversight, and at Johnson & Johnson, focusing on the analysis of safety signals from post-marketing data. Bongiovanni's career began at Novo Nordisk A/S as a Product Safety Manager, ensuring compliance in FDA reporting for adverse events. Education includes a Doctor of Pharmacy from the University of Florida, a Bachelor of Applied Science from Rutgers University, and a Bachelor of Business Administration from Bucknell University.